Yanagimoto H - Search Results

1

Novel concept of "sequential particle radiotherapy" with atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus.

Komatsu S, Terashima K, Ishihara N, Matsuo Y, Kido M, Yanagimoto H, Toyama H, Tokumaru S, Okimoto T, Fukumoto T. Komatsu S, et al. Among authors: yanagimoto h. Surg Today. 2024 Mar 4. doi: 10.1007/s00595-024-02805-1. Online ahead of print. Surg Today. 2024. PMID: 38436718

2

A Novel Method Using Gadolinium-Ethoxybenzyl Diethylenetriamine Pentaacetate Acid-Enhanced Magnetic Resonance Imaging for Predicting Post-Hepatectomy Liver Failure in Hepatocellular Carcinoma Patients with a Major Portal Vein Tumor Thrombus.

Nishio K, Komatsu S, Sofue K, Kido M, Kuramitsu K, Gon H, Fukushima K, Urade T, Yanagimoto H, Toyama H, Fukumoto T. Nishio K, et al. Among authors: yanagimoto h. Dig Surg. 2024;41(1):30-36. doi: 10.1159/000536157. Epub 2024 Jan 12. Dig Surg. 2024. PMID: 38219712

3

[A Case of Ampullary Carcinoma with Celiac Axis Stenosis That Underwent Pancreaticoduodenectomy and Arterial Reconstruction].

Okazoe Y, Tsugawa D, Yanagimoto H, Akita M, So S, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Fukumoto T. Okazoe Y, et al. Among authors: yanagimoto h. Gan To Kagaku Ryoho. 2023 Dec;50(13):1534-1536. Gan To Kagaku Ryoho. 2023. PMID: 38303332 Japanese.

4

Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma.

Ishihara N, Komatsu S, Sofue K, Ueshima E, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Toyama H, Ueda Y, Kodama Y, Murakami T, Fukumoto T. Ishihara N, et al. Among authors: yanagimoto h. Hepatol Res. 2024 Feb 14. doi: 10.1111/hepr.14024. Online ahead of print. Hepatol Res. 2024. PMID: 38353524

5

Spontaneous rupture of splenic hilar lymph node metastasis from hepatocellular carcinoma.

Fujinaka R, Urade T, Kido M, Komatsu S, Gon H, Fukushima K, Komatsu M, Yanagimoto H, Toyama H, Fukumoto T. Fujinaka R, et al. Among authors: yanagimoto h. Clin J Gastroenterol. 2024 Jun;17(3):557-562. doi: 10.1007/s12328-024-01928-9. Epub 2024 Feb 22. Clin J Gastroenterol. 2024. PMID: 38386256

6

Optimal cutoff values of drain amylase for predicting pancreatic fistula are different between open and laparoscopic distal pancreatectomy.

Ishida J, Toyama H, Asari S, Goto T, Nanno Y, Yoshida T, So S, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Yanagimoto H, Kido M, Fukumoto T. Ishida J, et al. Among authors: yanagimoto h. Surg Endosc. 2024 May;38(5):2699-2708. doi: 10.1007/s00464-024-10781-3. Epub 2024 Mar 25. Surg Endosc. 2024. PMID: 38528262

7

Water-Mediated On-Demand Detachable Solid-State Adhesive of Porous Hydroxyapatite for Internal Organ Retractions.

Okada M, Xie SC, Kobayashi Y, Yanagimoto H, Tsugawa D, Tanaka M, Nakano T, Fukumoto T, Matsumoto T. Okada M, et al. Among authors: yanagimoto h. Adv Healthc Mater. 2024 May 1:e2304616. doi: 10.1002/adhm.202304616. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38691405

8

Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report.

Ishihara N, Komatsu S, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Arai K, Yanagimoto H, Toyama H, Fukumoto T. Ishihara N, et al. Among authors: yanagimoto h. Oncol Lett. 2024 May 17;28(1):332. doi: 10.3892/ol.2024.14465. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38807678 Free PMC article.

9

The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection.

Gon H, Komatsu S, Omiya S, Kido M, Fukushima K, Urade T, Yoshida T, Arai K, Ishida J, Nanno Y, Tsugawa D, Yanagimoto H, Toyama H, Fukumoto T. Gon H, et al. Among authors: yanagimoto h. Anticancer Res. 2024 May;44(5):2031-2038. doi: 10.21873/anticanres.17006. Anticancer Res. 2024. PMID: 38677757

10

Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.

Koizumi A, Komatsu S, Omiya S, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, So S, Yoshida T, Arai K, Fujinaka R, Shimura Y, Yanagimoto H, Toyama H, Ueda Y, Kodama Y, Fukumoto T. Koizumi A, et al. Among authors: yanagimoto h. Anticancer Res. 2024 May;44(5):2055-2061. doi: 10.21873/anticanres.17009. Anticancer Res. 2024. PMID: 38677746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page